[ Back ]   [ More News ]   [ Home ]
MaxLinear, Inc. Announces Third Quarter 2019 Financial Results

CARLSBAD, Calif. — (BUSINESS WIRE) — October 24, 2019 — MaxLinear, Inc. (NYSE: MXL), a leading provider of RF, analog and mixed-signal integrated circuits for the connected home, and industrial and multi-market applications, today announced financial results for the third quarter ended September 30, 2019.

Third Quarter Financial Highlights

GAAP basis:

Non-GAAP basis:

Recent Business Highlights

Management Commentary

“In the third quarter, revenue results were in line with our guidance, gross margin remained solid, and operating expenses declined on disciplined execution. We also generated more than $21 million in cash from operations. We are focused on delivering our new 5G wireless radio and fiber-optic datacenter high-speed interconnect products as we expand into new large, high-growth infrastructure markets,” commented Kishore Seendripu, Ph.D., Chairman and CEO.

“We are excited to confirm our first 5G wireless radio-platform design-win at a tier-1 wireless OEM for our industry leading 14nm CMOS 4x4 Quad RF transceiver system-on-chip solution. Early customer evaluation feedback across major OEMs confirms that we are hitting the mark on the feature sets required by this demanding market. We are on track to see initial revenues in 2020 for the 5G market enabled by significant content increases per base station. In early 2020, we also expect production adoption of our 100 gigabit and 400 gigabit PAM4 DSP SoCs in the hyperscale data center market.” continued Dr. Seendripu.

Fourth Quarter 2019 Business Outlook

The company expects revenue in the fourth quarter 2019 to be approximately $67 million to $73 million. The Company also estimates the following:

Webcast and Conference Call

MaxLinear will host its third quarter financial results conference call today, October 24, 2019 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). To access this call, dial US toll free: 1-877-407-3109 / International: 1-201-493-6798. A live webcast of the conference call will be accessible from the investor relations section of the MaxLinear website at https://investors.maxlinear.com, and will be archived and available after the call at https://investors.maxlinear.com until November 7, 2019. A replay of the conference call will also be available until November 7, 2019 by dialing US toll free: 1-877-660-6853 / International: 1-201-612-7415 and Conference ID#: 13692485.

Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including specifically our current guidance for fourth quarter 2019 revenue, gross margins, and operating expenses) and statements concerning expectations of potential developments in our target markets, including management’s views with respect to the prospects for and trends in our connected home and 5G wireless and fiber-optic high-speed interconnect infrastructure markets. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties. Risks and uncertainties affecting our business and future operating results include, without limitation, intense competition in our industry; our dependence on a limited number of customers for a substantial portion of our revenues; uncertainties concerning how end user markets for our products will develop, including in particular new markets we are entering such as the 5G wireless and fiber-optic data center high-speed interconnect infrastructure markets but also existing markets such as connected home; uncertainties concerning the outcome of global trade negotiations, export control limitations, and heightened geopolitical risks generally; potential uncertainties arising from continued consolidation among cable television and satellite operators in our target markets and continued consolidation among competitors within the semiconductor industry generally; our ability to develop and introduce new and enhanced products on a timely basis and achieve market acceptance of those products, particularly as we seek to expand outside of our historic markets; potential decreases in average selling prices for our products; risks relating to intellectual property protection and the prevalence of intellectual property litigation in our industry; the impact on our financial condition of the indebtedness arising from the Exar transaction; our reliance on a limited number of third party manufacturers; and our lack of long-term supply contracts and dependence on limited sources of supply.

In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission (SEC), including our most recent Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on February 5, 2019, our Quarterly Reports on Form 10-Q for the quarter ended March 31, 2019 filed with the SEC on May 1, 2019 and for the quarter ended June 30, 2019 filed with the SEC on July 25, 2019, and our Current Reports on Form 8-K, as well as the information to be set forth under the caption “Risk Factors” in MaxLinear’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, which we expect to file shortly. All forward-looking statements are based on the estimates, projections and assumptions of management as of October 24, 2019, and MaxLinear is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.

Use of Non-GAAP Financial Measures

To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP gross margin, operating expenses, operating expenses as a percentage of revenue, income from operations as percentage of revenue, effective tax rate, net income and diluted earnings per share. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance based bonus plan for 2019, which we currently intend to settle in shares of our common stock; (iii) accruals related to our performance based bonus plan for 2018 which we settled in shares of common stock in 2019; (iv) amortization of purchased intangible assets; (v) depreciation of fixed assets step-up; (vi) professional fees and settlement costs related to our previously disclosed IP and commercial litigation matters; (vii) severance and other restructuring charges; (viii) non-cash income tax benefits and expenses and effects of the 2017 Tax Cuts and Jobs Act, or Tax Act, as applicable; and (ix) non-recurring gain on reversal of liability. These non-GAAP measures are not in accordance with and do not serve as an alternative for GAAP. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. These non-GAAP measures should only be viewed in conjunction with corresponding GAAP measures. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.

We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.

The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:

Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income.

Bonuses under our executive and non-executive bonus programs have been excluded from our non-GAAP net income for all periods reported. Bonus payments for the 2018 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in February 2019. We currently expect that bonus awards under our fiscal 2019 program will be settled in common stock in the first quarter of fiscal 2020.

Expenses incurred (gains recognized) in relation to acquisitions include amortization of purchased intangible assets, depreciation of step-up of property and equipment to fair value, and non-recurring gain on reversal of liability for an assumed indemnification obligation.

Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to exiting certain facilities.

Expenses incurred in relation to our intellectual property and commercial litigation include professional fees incurred.

Income tax benefits and expense adjustments are those that do not affect cash income taxes payable. Effects of the Tax Act were excluded from non-GAAP effective tax rate, as applicable.

Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, particularly related to stock-based compensation and its related tax effects as well as potential impairments, we have not provided a reconciliation for non-GAAP guidance provided for the fourth quarter 2019.

About MaxLinear, Inc.

MaxLinear, Inc. (NYSE: MXL) is a leading provider of radio frequency (RF), analog and mixed-signal integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit www.maxlinear.com.

MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

 

Three Months Ended

 

September 30, 2019

 

June 30, 2019

 

September 30, 2018

Net revenue

$

80,020

 

 

$

82,507

 

 

$

85,010

 

Cost of net revenue

38,116

 

 

38,427

 

 

41,134

 

Gross profit

41,904

 

 

44,080

 

 

43,876

 

Operating expenses:

 

 

 

 

 

Research and development

23,174

 

 

24,304

 

 

29,047

 

Selling, general and administrative

21,920

 

 

22,327

 

 

24,963

 

Impairment losses

 

 

 

 

2,198

 

Restructuring charges

144

 

 

416

 

 

236

 

Total operating expenses

45,238

 

 

47,047

 

 

56,444

 

Loss from operations

(3,334

)

 

(2,967

)

 

(12,568

)

Interest income

214

 

 

192

 

 

17

 

Interest expense

(2,718

)

 

(2,853

)

 

(3,473

)

Other income (expense), net

1,098

 

 

(14

)

 

39

 

Total interest and other expense, net

(1,406

)

 

(2,675

)

 

(3,417

)

Loss before income taxes

(4,740

)

 

(5,642

)

 

(15,985

)

Income tax benefit

(26

)

 

(3,413

)

 

(2,050

)

Net loss

$

(4,714

)

 

$

(2,229

)

 

$

(13,935

)

Net loss per share:

 

 

 

 

 

Basic

$

(0.07

)

 

$

(0.03

)

 

$

(0.20

)

Diluted

$

(0.07

)

 

$

(0.03

)

 

$

(0.20

)

Shares used to compute net loss per share:

 

 

 

 

 

Basic

71,366

 

 

70,917

 

 

68,742

 

Diluted

71,366

 

 

70,917

 

 

68,742

 

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

 

Nine Months Ended

 

September 30, 2019

 

September 30, 2018

Net revenue

$

247,162

 

 

$

297,370

 

Cost of net revenue

116,101

 

 

134,496

 

Gross profit

131,061

 

 

162,874

 

Operating expenses:

 

 

 

Research and development

74,877

 

 

90,379

 

Selling, general and administrative

67,838

 

 

76,581

 

Impairment losses

 

 

2,198

 

Restructuring charges

2,477

 

 

2,101

 

Total operating expenses

145,192

 

 

171,259

 

Loss from operations

(14,131

)

 

(8,385

)

Interest income

553

 

 

54

 

Interest expense

(8,546

)

 

(11,061

)

Other income (expense), net

429

 

 

193

 

Total interest and other expense, net

(7,564

)

 

(10,814

)

Loss before income taxes

(21,695

)

 

(19,199

)

Income tax provision (benefit)

(9,901

)

 

7,311

 

Net loss

$

(11,794

)

 

$

(26,510

)

Net loss per share:

 

 

 

Basic

$

(0.17

)

 

$

(0.39

)

Diluted

$

(0.17

)

 

$

(0.39

)

Shares used to compute net loss per share:

 

 

 

Basic

70,755

 

 

68,256

 

Diluted

70,755

 

 

68,256

 

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

Three Months Ended

 

September 30, 2019

 

June 30, 2019

 

September 30, 2018

Operating Activities

 

 

 

 

 

Net loss

$

(4,714

)

 

$

(2,229

)

 

$

(13,935

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

Amortization and depreciation

16,419

 

 

16,646

 

 

19,767

 

Impairment losses

 

 

 

 

2,198

 

Amortization of debt issuance costs and accretion of discount on debt and leases

380

 

 

391

 

 

287

 

Stock-based compensation

8,359

 

 

8,207

 

 

7,940

 

Deferred income taxes

(1,379

)

 

(4,600

)

 

304

 

Loss on disposal of property and equipment

 

 

11

 

 

 

Gain on foreign currency

(183

)

 

(54

)

 

(184

)

Excess tax benefits on stock-based awards

(61

)

 

(2,074

)

 

(93

)

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

280

 

 

3,022

 

 

25,016

 

Inventory

5,108

 

 

(122

)

 

2,581

 

Prepaid expenses and other assets

960

 

 

(648

)

 

712

 

Leased right-of-use assets

1,309

 

 

981

 

 

 

Accounts payable, accrued expenses and other current liabilities

(6,313

)

 

2,961

 

 

(10,606

)

Accrued compensation

730

 

 

(209

)

 

2,671

 

Accrued price protection liability

2,291

 

 

(7,649

)

 

(5,662

)

Lease liabilities

(2,183

)

 

(2,179

)

 

 

Other long-term liabilities

749

 

 

(11

)

 

(275

)

Net cash provided by operating activities

21,752

 

 

12,444

 

 

30,721

 

Investing Activities

 

 

 

 

 

Purchases of property and equipment

(1,219

)

 

(524

)

 

(1,609

)

Purchases of intangible assets

(86

)

 

 

 

 

Net cash used in investing activities

(1,305

)

 

(524

)

 

(1,609

)

Financing Activities

 

 

 

 

 

Repayment of debt

(20,000

)

 

(15,000

)

 

(35,000

)

Net proceeds from issuance of common stock

288

 

 

3,305

 

 

91

 

Minimum tax withholding paid on behalf of employees for restricted stock units

(1,339

)

 

(5,408

)

 

(1,178

)

Net cash used in financing activities

(21,051

)

 

(17,103

)

 

(36,087

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

90

 

 

354

 

 

103

 

Decrease in cash, cash equivalents and restricted cash

(514

)

 

(4,829

)

 

(6,872

)

Cash, cash equivalents and restricted cash at beginning of period

67,038

 

 

71,867

 

 

75,115

 

Cash, cash equivalents and restricted cash at end of period

$

66,524

 

 

$

67,038

 

 

$

68,243

 

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

Nine Months Ended

 

September 30, 2019

 

September 30, 2018

Operating Activities

 

 

 

Net loss

$

(11,794

)

 

$

(26,510

)

Adjustments to reconcile net loss to cash provided by operating activities:

 

 

 

Amortization and depreciation

49,928

 

 

59,902

 

Impairment losses

 

 

2,198

 

Amortization of debt issuance costs and accretion of discount on debt and leases

1,173

 

 

861

 

Stock-based compensation

24,313

 

 

23,722

 

Deferred income taxes

(12,455

)

 

(3,317

)

Loss on disposal of property and equipment

46

 

 

 

Impairment of leasehold improvements

1,442

 

 

700

 

Impairment of long-lived assets

2,182

 

 

 

Gain on extinguishment of lease liabilities

(2,880

)

 

 

(Gain) loss on foreign currency

330

 

 

(541

)

Excess tax benefits on stock-based awards

(3,872

)

 

(1,208

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

3,160

 

 

7,462

 

Inventory

3,971

 

 

11,677

 

Prepaid expenses and other assets

916

 

 

3,928

 

Leased right-of-use assets

2,935

 

 

 

Accounts payable, accrued expenses and other current liabilities

(1,431

)

 

513

 

Accrued compensation

1,414

 

 

6,574

 

Deferred revenue and deferred profit

 

 

(138

)

Accrued price protection liability

(2,869

)

 

(7,153

)

Lease liabilities

(6,487

)

 

 

Other long-term liabilities

219

 

 

(154

)

Net cash provided by operating activities

50,241

 

 

78,516

 

Investing Activities

 

 

 

Purchases of property and equipment

(3,898

)

 

(6,413

)

Purchases of intangible assets

(86

)

 

 

Net cash used in investing activities

(3,984

)

 

(6,413

)

Financing Activities

 

 

 

Repayment of debt

(50,000

)

 

(78,000

)

Net proceeds from issuance of common stock

6,221

 

 

4,107

 

Minimum tax withholding paid on behalf of employees for restricted stock units

(11,166

)

 

(5,017

)

Net cash used in financing activities

(54,945

)

 

(78,910

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

1,021

 

 

638

 

Decrease in cash, cash equivalents and restricted cash

(7,667

)

 

(6,169

)

Cash, cash equivalents and restricted cash at beginning of period

74,191

 

 

74,412

 

Cash, cash equivalents and restricted cash at end of period

$

66,524

 

 

$

68,243

 

MAXLINEAR, INC.

UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

September 30, 2019

 

June 30, 2019

 

September 30, 2018 (1)

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

66,115

 

 

$

66,629

 

 

$

67,185

 

Short-term restricted cash

345

 

 

344

 

 

349

 

Accounts receivable, net

56,339

 

 

56,618

 

 

58,633

 

Inventory

37,642

 

 

42,875

 

 

41,757

 

Prepaid expenses and other current assets

4,679

 

 

6,184

 

 

6,329

 

Total current assets

165,120

 

 

172,650

 

 

174,253

 

Long-term restricted cash

64

 

 

65

 

 

709

 

Property and equipment, net

15,204

 

 

15,738

 

 

19,413

 

Leased right-of-use assets

18,719

 

 

20,624

 

 

 

Intangible assets, net

202,217

 

 

216,342

 

 

261,813

 

Goodwill

238,330

 

 

238,330

 

 

238,330

 

Deferred tax assets

64,046

 

 

62,667

 

 

42,691

 

Other long-term assets

3,065

 

 

2,744

 

 

4,935

 

Total assets

$

706,765

 

 

$

729,160

 

 

$

742,144

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities

$

63,119

 

 

$

66,918

 

 

$

66,464

 

Long-term lease liabilities

14,995

 

 

16,515

 

 

 

Long-term debt

206,622

 

 

226,335

 

 

270,470

 

Other long-term liabilities

8,678

 

 

8,016

 

 

12,816

 

Stockholders’ equity

413,351

 

 

411,376

 

 

392,394

 

Total liabilities and stockholders’ equity

$

706,765

 

 

$

729,160

 

 

$

742,144

 

_____________

(1) Long-term lease liabilities have been reclassified from other long-term liabilities to conform to current period presentation.

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS

(in thousands, except per share data)

 

 

Three Months Ended

 

September 30, 2019

 

June 30, 2019

 

September 30, 2018

GAAP gross profit

$

41,904

 

 

$

44,080

 

 

$

43,876

 

Stock-based compensation

151

 

 

147

 

 

131

 

Performance based equity

 

 

 

 

53

 

Amortization of purchased intangible assets

8,477

 

 

8,478

 

 

8,969

 

Depreciation of fixed asset step-up

 

 

 

 

95

 

Non-GAAP gross profit

50,532

 

 

52,705

 

 

53,124

 

 

 

 

 

 

 

GAAP R&D expenses

23,174

 

 

24,304

 

 

29,047

 

Stock-based compensation

(4,155

)

 

(4,222

)

 

(4,726

)

Performance based equity

(45

)

 

 

 

(1,517

)

Depreciation of fixed asset step-up

 

 

 

 

(321

)

Non-GAAP R&D expenses

18,974

 

 

20,082

 

 

22,483

 

 

 

 

 

 

 

GAAP SG&A expenses

21,920

 

 

22,327

 

 

24,963

 

Stock-based compensation

(4,068

)

 

(3,823

)

 

(3,070

)

Performance based equity

(279

)

 

 

 

(785

)

Amortization of purchased intangible assets

(5,722

)

 

(5,792

)

 

(7,994

)

Depreciation of fixed asset step-up

 

 

 

 

(12

)

IP litigation costs, net

(71

)

 

(13

)

 

(19

)

Non-GAAP SG&A expenses

11,780

 

 

12,699

 

 

13,083

 

 

 

 

 

 

 

GAAP impairment losses

 

 

 

 

2,198

 

Impairment losses

 

 

 

 

(2,198

)

Non-GAAP impairment losses

 

 

 

 

 

 

 

 

 

 

 

GAAP restructuring expenses

144

 

 

416

 

 

236

 

Restructuring charges

(144

)

 

(416

)

 

(236

)

Non-GAAP restructuring expenses

 

 

 

 

 

 

 

 

 

 

 

GAAP loss from operations

(3,334

)

 

(2,967

)

 

(12,568

)

Total non-GAAP adjustments

23,112

 

 

22,891

 

 

30,126

 

Non-GAAP income from operations

19,778

 

 

19,924

 

 

17,558

 

 

 

 

 

 

 

GAAP and non-GAAP interest and other income (expense), net

(1,406

)

 

(2,675

)

 

(3,417

)

Non-recurring gain on reversal of liability

(1,006

)

 

 

 

 

Non-GAAP interest and other income (expense), net

(2,412

)

 

(2,675

)

 

(3,417

)

 

 

 

 

 

 

GAAP loss before income taxes

(4,740

)

 

(5,642

)

 

(15,985

)

Total non-GAAP adjustments

22,106

 

 

22,891

 

 

30,126

 

Non-GAAP income before income taxes

17,366

 

 

17,249

 

 

14,141

 

 

 

 

 

 

 

GAAP income tax benefit

(26

)

 

(3,413

)

 

(2,050

)

Adjustment for non-cash tax benefits/expenses and effects of the Tax Act

894

 

 

4,621

 

 

3,040

 

Non-GAAP income tax provision

868

 

 

1,208

 

 

990

 

 

 

 

 

 

 

GAAP net loss

(4,714

)

 

(2,229

)

 

(13,935

)

Total non-GAAP adjustments before income taxes

22,106

 

 

22,891

 

 

30,126

 

Less: total tax adjustments

894

 

 

4,621

 

 

3,040

 

Non-GAAP net income

$

16,498

 

 

$

16,041

 

 

$

13,151

 

 

 

 

 

 

 

Shares used in computing non-GAAP basic net income per share

71,366

 

 

70,917

 

 

68,742

 

Shares used in computing non-GAAP diluted net income per share

72,506

 

 

72,389

 

 

70,634

 

Non-GAAP basic net income per share

$

0.23

 

 

$

0.23

 

 

$

0.19

 

Non-GAAP diluted net income per share

$

0.23

 

 

$

0.22

 

 

$

0.19

 

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS

(in thousands, except per share data)

 

 

Nine Months Ended

 

September 30, 2019

 

September 30, 2018

GAAP gross profit

$

131,061

 

 

$

162,874

 

Stock-based compensation

428

 

 

357

 

Performance based equity

73

 

 

178

 

Amortization of purchased intangible assets

25,379

 

 

26,906

 

Depreciation of fixed asset step-up

 

 

303

 

Non-GAAP gross profit

156,941

 

 

190,618

 

 

 

 

 

GAAP R&D expenses

74,877

 

 

90,379

 

Stock-based compensation

(12,590

)

 

(13,554

)

Performance based equity

(970

)

 

(3,954

)

Depreciation of fixed asset step-up

(6

)

 

(974

)

Non-GAAP R&D expenses

61,311

 

 

71,897

 

 

 

 

 

GAAP SG&A expenses

67,838

 

 

76,581

 

Stock-based compensation

(11,295

)

 

(9,798

)

Performance based equity

(1,218

)

 

(2,564

)

Amortization of purchased intangible assets

(17,312

)

 

(23,982

)

Depreciation of fixed asset step-up

 

 

(34

)

IP litigation costs, net

(84

)

 

(80

)

Non-GAAP SG&A expenses

37,929

 

 

40,123

 

 

 

 

 

GAAP impairment losses

 

 

2,198

 

Impairment losses

 

 

(2,198

)

Non-GAAP impairment losses

 

 

 

 

 

 

 

GAAP restructuring expenses

2,477

 

 

2,101

 

Restructuring charges

(2,477

)

 

(2,101

)

Non-GAAP restructuring expenses

 

 

 

 

 

 

 

GAAP loss from operations

(14,131

)

 

(8,385

)

Total non-GAAP adjustments

71,832

 

 

86,983

 

Non-GAAP income from operations

57,701

 

 

78,598

 

 

 

 

 

GAAP and non-GAAP interest and other income (expense), net

(7,564

)

 

(10,814

)

Non-recurring gain on reversal of liability

(1,006

)

 

 

Non-GAAP interest and other income (expense), net

(8,570

)

 

(10,814

)

 

 

 

 

GAAP loss before income taxes

(21,695

)

 

(19,199

)

Total non-GAAP adjustments

70,826

 

 

86,983

 

Non-GAAP income before income taxes

49,131

 

 

67,784

 

 

 

 

 

GAAP income tax provision (benefit)

(9,901

)

 

7,311

 

Adjustment for non-cash tax benefits/expenses and effects of the Tax Act

12,993

 

 

(2,566

)

Non-GAAP income tax provision

3,092

 

 

4,745

 

 

 

 

 

GAAP net loss

(11,794

)

 

(26,510

)

Total non-GAAP adjustments before income taxes

70,826

 

 

86,983

 

Less: total tax adjustments

12,993

 

 

(2,566

)

Non-GAAP net income

$

46,039

 

 

$

63,039

 

 

 

 

 

Shares used in computing non-GAAP basic net income per share

70,755

 

 

68,256

 

Shares used in computing non-GAAP diluted net income per share

72,270

 

 

70,521

 

Non-GAAP basic net income per share

$

0.65

 

 

$

0.92

 

Non-GAAP diluted net income per share

$

0.64

 

 

$

0.89

 

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

 

 

Three Months Ended

 

September 30, 2019

 

June 30, 2019

 

September 30, 2018

GAAP gross profit

52.4

%

 

53.4

%

 

51.6

%

Stock-based compensation

0.2

%

 

0.2

%

 

0.2

%

Performance based equity

%

 

%

 

0.1

%

Amortization of purchased intangible assets

10.6

%

 

10.3

%

 

10.6

%

Depreciation of fixed asset step-up

%

 

%

 

0.1

%

Non-GAAP gross profit

63.1

%

 

63.9

%

 

62.5

%

 

 

 

 

 

 

GAAP R&D expenses

29.0

%

 

29.5

%

 

34.2

%

Stock-based compensation

(5.2

)%

 

(5.1

)%

 

(5.6

)%

Performance based equity

(0.1

)%

 

%

 

(1.8

)%

Depreciation of fixed asset step-up

%

 

%

 

(0.5

)%

Non-GAAP R&D expenses

23.7

%

 

24.3

%

 

26.4

%

 

 

 

 

 

 

GAAP SG&A expenses

27.4

%

 

27.1

%

 

29.4

%

Stock-based compensation

(5.1

)%

 

(4.6

)%

 

(3.6

)%

Performance based equity

(0.3

)%

 

%

 

(0.9

)%

Amortization of purchased intangible assets

(7.2

)%

 

(7.0

)%

 

(9.4

)%

Depreciation of fixed asset step-up

%

 

%

 

%

IP litigation costs, net

(0.1

)%

 

%

 

%

Non-GAAP SG&A expenses

14.7

%

 

15.4

%

 

15.4

%

 

 

 

 

 

 

GAAP impairment losses

%

 

%

 

2.6

%

Impairment losses

%

 

%

 

(2.6

)%

Non-GAAP impairment losses

%

 

%

 

%

 

 

 

 

 

 

GAAP restructuring expenses

0.2

%

 

0.5

%

 

0.3

%

Restructuring charges

(0.2

)%

 

(0.5

)%

 

(0.3

)%

Non-GAAP restructuring expenses

%

 

%

 

%

 

 

 

 

 

 

GAAP loss from operations

(4.2

)%

 

(3.6

)%

 

(14.8

)%

Total non-GAAP adjustments

28.9

%

 

27.7

%

 

35.4

%

Non-GAAP income from operations

24.7

%

 

24.1

%

 

20.7

%

 

 

 

 

 

 

GAAP interest and other income (expense), net

(1.8

)%

 

(3.2

)%

 

(4.0

)%

Nonrecurring gain on reversal of liability

(1.3

)%

 

%

 

%

Non-GAAP interest and other income (expense), net

(3.0

)%

 

(3.2

)%

 

(4.0

)%

 

 

 

 

 

 

GAAP loss before income taxes

(5.9

)%

 

(6.8

)%

 

(18.8

)%

Total non-GAAP adjustments before income taxes

27.6

%

 

27.7

%

 

35.4

%

Non-GAAP income before income taxes

21.7

%

 

20.9

%

 

16.6

%

 

 

 

 

 

 

GAAP income tax benefit

%

 

(4.1

)%

 

(2.4

)%

Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act

1.1

%

 

5.6

%

 

3.6

%

Non-GAAP income tax provision

1.1

%

 

1.5

%

 

1.2

%

 

 

 

 

 

 

GAAP net loss

(5.9

)%

 

(2.7

)%

 

(16.4

)%

Total non-GAAP adjustments before income taxes

27.6

%

 

27.7

%

 

35.4

%

Less: total tax adjustments

1.1

%

 

5.6

%

 

3.6

%

Non-GAAP net income

20.6

%

 

19.4

%

 

15.5

%

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

 

 

Nine Months Ended

 

September 30, 2019

 

September 30, 2018

GAAP gross profit

53.0

%

 

54.8

%

Stock-based compensation

0.2

%

 

0.1

%

Performance based equity

%

 

0.1

%

Amortization of purchased intangible assets

10.3

%

 

9.0

%

Depreciation of fixed asset step-up

%

 

0.1

%

Non-GAAP gross profit

63.5

%

 

64.1

%

 

 

 

 

GAAP R&D expenses

30.3

%

 

30.4

%

Stock-based compensation

(5.1

)%

 

(4.6

)%

Performance based equity

(0.4

)%

 

(1.3

)%

Depreciation of fixed asset step-up

%

 

(0.3

)%

Non-GAAP R&D expenses

24.8

%

 

24.2

%

 

 

 

 

GAAP SG&A expenses

27.4

%

 

25.8

%

Stock-based compensation

(4.6

)%

 

(3.3

)%

Performance based equity

(0.5

)%

 

(0.9

)%

Amortization of purchased intangible assets

(7.0

)%

 

(8.1

)%

Depreciation of fixed asset step-up

%

 

%

IP litigation costs, net

%

 

%

Non-GAAP SG&A expenses

15.3

%

 

13.5

%

 

 

 

 

GAAP impairment losses

%

 

0.7

%

Impairment losses

%

 

(0.7

)%

Non-GAAP impairment losses

%

 

%

 

 

 

 

GAAP restructuring expenses

1.0

%

 

0.7

%

Restructuring charges

(1.0

)%

 

(0.7

)%

Non-GAAP restructuring expenses

%

 

%

 

 

 

 

GAAP loss from operations

(5.7

)%

 

(2.8

)%

Total non-GAAP adjustments

29.1

%

 

29.3

%

Non-GAAP income from operations

23.3

%

 

26.4

%

 

 

 

 

GAAP interest and other income (expense), net

(3.1

)%

 

(3.6

)%

Nonrecurring gain on reversal of liability

(0.4

)%

 

%

Non-GAAP interest and other income (expense), net

(3.5

)%

 

(3.6

)%

 

 

 

 

GAAP loss before income taxes

(8.8

)%

 

(6.5

)%

Total non-GAAP adjustments before income taxes

28.7

%

 

29.3

%

Non-GAAP income before income taxes

19.9

%

 

22.8

%

 

 

 

 

GAAP income tax provision (benefit)

(4.0

)%

 

2.5

%

Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act

5.3

%

 

(0.9

)%

Non-GAAP income tax provision

1.3

%

 

1.6

%

 

 

 

 

GAAP net loss

(4.8

)%

 

(8.9

)%

Total non-GAAP adjustments before income taxes

28.7

%

 

29.3

%

Less: total tax adjustments

5.3

%

 

(0.9

)%

Non-GAAP net income

18.6

%

 

21.2

%

 



Contact:

MaxLinear, Inc. Investor Relations Contact:
Steven Litchfield
Tel: 949-333-0080
Email Contact